Annovis Bio Inc (ANVS)

Millions of Americans are struggling with Alzheimer's, according to the Alzheimer’s Association. The disease often has a slow progression, lasting years or even decades, and it's…

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Jul 30, 2021

We've got one more day of trading before the weekend so let's start it off with the biggest pre-market stock market movers for Friday.

ANVS Stock: The Alzheimer’s Drug News That Has Annovis Bio Plunging Today

By Nick Clarkson, Web Editor Jul 29, 2021

Shares of ANVS stock are plummeting on Thursday after Annovis Bio reported weak results from two clinical trials for its leading drug.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Jul 29, 2021

Good morning! We're kicking off another busy day of trading with a dive into the biggest pre-market stock movers for Thursday.

7 Top-Rated Pharmaceutical Companies to Invest In for July

By Louis Navellier and the InvestorPlace Research Staff Jul 9, 2021

Pharma stocks like MNMD stock and ANVS stock offer investors long-term growth potential in a market on track to hit a value of $1.70 trillion.

3 Better Alzheimer’s Drug Stocks to Buy Instead of Biogen

By Muslim Farooque, InvestorPlace Contributor Jun 29, 2021

These drug stocks are in competition with Biogen for an Alzheimer's treatment, and can break out in a similar fashion offering better value.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer May 24, 2021

We're kicking off another exciting week of trading with a look at the biggest pre-market stock movers for Monday morning.

ANVS Stock: The Huge News Sending Annovis Bio Rocketing 200% Today

By Brenden Rearick, InvestorPlace Financial News Writer May 21, 2021

A dual Alzheimer's-Parkinson's clinical trial is showing highly optimistic results for Annovis, and ANVS stock is up huge because of it.

Annovis Bio falls after Brookline Capital downgrades on PD trial complications (NYSE:ANVS)

From Seeking Alpha Feb 28, 2024

Orbon Alija/E+ via Getty Images Annovis Bio (NYSE:ANVS) shares fell in early trade on Wednesday after Brookline Capital Markets downgraded the company’s...

Annovis Bio files for $250M mixed shelf (NYSE:ANVS)

From Seeking Alpha Feb 1, 2024

Annovis Bio files prospectus for a proposed mixed shelf offering of up to $250M, as per SEC filing.

Annovis falls 16% on Phase 3 data delay for Parkinson's drug (NYSE:ANVS)

From Seeking Alpha Jan 24, 2024

Shares of Annovis Bio (ANVS) tumbled 16% in morning trading Wednesday after the company said the release of Phase 3 data for its Parkinson’s disease drug candid

Doing Your Holiday Shopping? These Stocks Might Make Great Gifts

From MarketBeat Dec 4, 2023

No matter which holiday you're planning gifts for, Christmas, Hanukkah, or some other occasion, there may be one great gift idea you haven't thought of yet.

H.C. Wainwright Sticks to Its Buy Rating for Annovis Bio (ANVS)

From TipRanks Oct 11, 2022

In a report released yesterday, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Annovis Bio (ANVS – Research Report), with a price target of $40...

Annovis Bio (ANVS) Gets a Buy from Maxim Group

From TipRanks Aug 25, 2022

Maxim Group analyst Jason McCarthy maintained a Buy rating on Annovis Bio (ANVS – Research Report) yesterday and set a price target of $26.00. The company&#82...

Annovis Bio Inc (ANVS)

ANVS Stock Earnings: Annovis Bio Misses EPS for Q4 2023

Sell Signal: 3 Stocks to Unload Before the Bubble Bursts

3 Growth Stocks to Sell in February Before They Bottom

3 Biotech Stocks to Buy Before Drug Trials End

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Annovis Bio Inc (ANVS)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

ANVS Stock Predictions, Articles, and Annovis Bio Inc News

Subscriber Sign in